Cancer-associated thrombosis (CAT) is a common yet often poorly understood complication of cancer. Historically, management was largely limited to

Cancer-associated thrombosis (CAT) is a common yet often poorly understood complication of cancer. Historically, management was largely limited to

The Cribsiders · Episode

Cancer-associated thrombosis (CAT) is a common yet often poorly understood complication of cancer. Historically, management was largely limited to

The data “give you pause” when considering closure, especially for women who can tolerate DOACs, Christine Albert says.

Choosing which antiseizure medications to give patients with epilepsy who are taking direct oral anticoagulant therapy is important for avoiding thromboembolic and bleeding risks.

Cancer-associated thrombosis (CAT) is a common yet often poorly understood complication of cancer. Historically, management was largely limited to

The data “give you pause” when considering closure, especially for women who can tolerate DOACs, Christine Albert says.

A stroke may be preventable even when atrial fibrillation falls below the high-risk threshold, with blood-thinning drugs reducing serious complications without increasing major bleeding. The SINGLE-AF trial provides the first randomized evidence that direct oral anticoagulants (DOACs) can benefit people with atrial fibrillation and an intermediate risk of stroke. Over two years, these medications reduced [...]

CLOSURE-AF: Worse Outcomes With LAAO Driven by Results in Women mosbey@crf.org Fri, 09/11/2026 - 15:28 Todd Neale The data “give you pause” when considering closure, especially for women who can tolerate DOACs, Christine Albert says.

A stroke may be preventable even when atrial fibrillation falls below the high-risk threshold, with blood-thinning drugs reducing serious complications without increasing major bleeding. The SINGLE-AF trial provides the first randomized evidence that direct oral anticoagulants (DOACs) can benefit people with atrial fibrillation and an intermediate risk of stroke. Over two years, these medications reduced [...]

Anticoagulation reduced adverse clinical events in patients with atrial fibrillation at intermediate stroke risk, without an apparent increase in major bleeding.

HALT reduced without increase in safety events compared with aspirin

ACASA-TAVI and NOTION-4 Trials Give Mixed Messages on DOACs After TAVI mosbey@crf.org Tue, 09/01/2026 - 08:36 Todd Neale

HALT reduced without increase in safety events compared with aspirin

Because of the low number of events in the trial, the findings are thought-provoking but not definitive, one expert says.

SINGLE-AF trial shows cardiovascular protection without unacceptable bleeding

DOACs Benefit AF Patients With Intermediate Stroke Risk: SINGLE-AF ccox@crf.org Fri, 08/28/2026 - 05:16 Todd Neale Because of the low number of events in the trial, the findings are thought-provoking but not definitive, one expert says.